Search hospitals > Montana > Missoula

Community Medical Hospital

Claim this profile
Missoula, Montana 59804
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
396 reported clinical trials
2 medical researchers
Photo of Community Medical Hospital in MissoulaPhoto of Community Medical Hospital in MissoulaPhoto of Community Medical Hospital in Missoula

Summary

Community Medical Hospital is a medical facility located in Missoula, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Community Medical Hospital is involved with conducting 396 clinical trials across 492 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.

Area of expertise

1Cancer
Global Leader
Community Medical Hospital has run 131 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Community Medical Hospital has run 71 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Community Medical Hospital

Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Pancreatic Cancer
Ovarian Cancer
Rectal Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Community Medical Hospital?
Community Medical Hospital is a medical facility located in Missoula, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Community Medical Hospital is involved with conducting 396 clinical trials across 492 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.
Where is Community Medical Hospital located?
Community Medical Center is located at 2827 Fort Missoula Rd, Missoula, MT. For real-time traffic updates and road conditions, consider using Waze to navigate.
Who should I call to ask about financial aid or insurance network?
**Community Medical Hospital Financial Assistance** - **Patient Financial Services:** For financial assistance, please call (559) 459-3939 or toll-free at (800) 773-2223 ext. 53939. - **Insurance Inquiries:** For questions regarding insurance, contact our hospital billing customer service at 844-425-0501.
What insurance does Community Medical Hospital accept?
Community Medical Hospital accepts a wide range of insurance plans, including Medicaid, Medicare, CHIP, and major insurances such as Empire Blue Cross Blue Shield, United Healthcare, Aetna, and Cigna Dental, among others. They cater to various plan types, including HMOs, PPOs, dental, and behavioral health plans. For specific coverage details, it is advised to contact the hospital directly or consult with your insurance provider.
What awards or recognition has Community Medical Hospital received?
**Community Medical Hospital, Missoula, Montana** - Recognized as one of America's safest hospitals. - Partnered with the Montana Cancer Consortium to conduct clinical trials. - Focus on advancing cancer treatment, diagnosis, prevention, and symptom management.